showed that obesity decreases mortality risk more among HFpEF patients than among HFrEF patients, but this finding did not reach statistical significance. 24 In effect, BMI changes can mask the risk of mortality for obese patients, who may have worse prognoses post HF and remain to be further studied.
← all excerpts
Heterogeneity in cardiovascular death or hospitalization for heart failure benefits with flozins is linked to weight.
1
—
—